SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001558370-20-000146
Filing Date
2020-01-14
Accepted
2020-01-14 10:01:15
Documents
5
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A f10-qa.htm 10-Q/A 68564
2 EX-31.1 ex-31d1.htm EX-31.1 13676
3 EX-31.2 ex-31d2.htm EX-31.2 13534
4 EX-32.1 ex-32d1.htm EX-32.1 9823
5 GRAPHIC f10-qag001.jpg GRAPHIC 1558
  Complete submission text file 0001558370-20-000146.txt   109016
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-35182 | Film No.: 20525144
SIC: 2834 Pharmaceutical Preparations